Academic and Community Cancer Research United

A cancer research network conducting clinical trials that translate the latest

discoveries into new therapies for cancer treatment and symptom management

Clinical Trials

Expertise leads to innovation

ACCRU network physicians and scientists collaborate with industry partners and research networks to design and implement high-quality clinical trials to test the latest cancer treatments and symptom management therapies.

Most ACCRU trials are phase II and phase III studies. We offer the opportunity to develop many types of trials:


  • Industry-led trials
  • Investigator-initiated trials
  • Industry-written trials with investigator input
  • Food and Drug Administration (FDA) registration trials

Treatment trials

  • Acute leukemia
  • Brain cancer
  • Breast cancer
  • Chronic lymphocytic leukemia
  • Chronic myeloid disorders
  • Colorectal cancer
  • Gastro-esophageal cancer
  • Head and neck cancer
  • Hepatobiliary cancer
  • Lung cancer
  • Lymphoma
  • Melanoma
  • Myelodysplastic syndrome (MDS)
  • Myeloma
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Renal cell carcinoma
  • Sarcoma
  • Thyroid cancer

Symptom control trials

  • Anemia
  • Anorexia
  • Cancer associated thrombosis
  • Hot flashes
  • Osteopenia
  • Peripheral neuropathy
  • Skin toxicity


Quality-of-life/patient-reported outcomes research

ACCRU researchers incorporate patient survey tools to address clinical research questions in cancer treatment and cancer control studies.


Contact us to learn more about ACCRU clinical trials.